898 related articles for article (PubMed ID: 16181220)
21. Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source.
Blin N; Traineau R; Houssin S; Peffault de Latour R; Petropoulou A; Robin M; Larghero J; Ribaud P; Socié G
Biol Blood Marrow Transplant; 2010 Sep; 16(9):1315-23. PubMed ID: 20353831
[TBL] [Abstract][Full Text] [Related]
22. Impact of nonmyeloablative conditioning regimens on the occurrence of pure red cell aplasia after ABO-incompatible allogeneic haematopoietic stem cell transplantation.
Malfuson JV; Amor RB; Bonin P; Rodet M; Boccaccio C; Pautas C; Kuentz M; Cordonnier C; Noizat-Pirenne F; Maury S
Vox Sang; 2007 Jan; 92(1):85-9. PubMed ID: 17181595
[TBL] [Abstract][Full Text] [Related]
23. Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning.
Worel N; Greinix HT; Keil F; Mitterbauer M; Lechner K; Fischer G; Mayr W; Höcker P; Kalhs P
Transfusion; 2002 Oct; 42(10):1293-301. PubMed ID: 12423513
[TBL] [Abstract][Full Text] [Related]
24. Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion.
Verholen F; Stalder M; Helg C; Chalandon Y
Eur J Haematol; 2004 Dec; 73(6):441-6. PubMed ID: 15522068
[TBL] [Abstract][Full Text] [Related]
25. In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation.
Webb IJ; Soiffer RJ; Andersen JW; Cohen CA; Freeman A; Sugrue M; Ritz J; Anderson KC
Biol Blood Marrow Transplant; 1997 Nov; 3(5):267-72. PubMed ID: 9450922
[TBL] [Abstract][Full Text] [Related]
26. Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning.
Veelken H; Wäsch R; Behringer D; Bertz H; Finke J
Bone Marrow Transplant; 2000 Oct; 26(8):911-5. PubMed ID: 11081395
[TBL] [Abstract][Full Text] [Related]
27. ABO blood group barrier in allogeneic bone marrow transplantation revisited.
Seebach JD; Stussi G; Passweg JR; Loberiza FR; Gajewski JL; Keating A; Goerner M; Rowlings PA; Tiberghien P; Elfenbein GJ; Gale RP; van Rood JJ; Reddy V; Gluckman E; Bolwell BJ; Klumpp TR; Horowitz MM; Ringdén O; Barrett AJ;
Biol Blood Marrow Transplant; 2005 Dec; 11(12):1006-13. PubMed ID: 16338623
[TBL] [Abstract][Full Text] [Related]
28. [Pure red cell aplasia after allogeneic transplantation of ABO incompatible hematopoietic stem cells].
Bullorsky E; Shanley C; Stemmelin G; Ceresetto J; Rabinovich O
Medicina (B Aires); 2002; 62(6):575-7. PubMed ID: 12532694
[TBL] [Abstract][Full Text] [Related]
29. Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation.
Griffith LM; McCoy JP; Bolan CD; Stroncek DF; Pickett AC; Linton GF; Lundqvist A; Srinivasan R; Leitman SF; Childs RW
Br J Haematol; 2005 Mar; 128(5):668-75. PubMed ID: 15725089
[TBL] [Abstract][Full Text] [Related]
30. [ABO-incompatible allogeneic bone marrow transplantation].
Xu L; Guo N; Wang S
Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):413-5. PubMed ID: 11721421
[TBL] [Abstract][Full Text] [Related]
31. Impact of ABO incompatibility on engraftment and transfusion requirement after unrelated cord blood transplantation: a single institute experience in Japan.
Tomonari A; Takahashi S; Ooi J; Tsukada N; Konuma T; Kobayashi T; Sato A; Iseki T; Yamaguchi T; Tojo A; Asano S
Bone Marrow Transplant; 2007 Sep; 40(6):523-8. PubMed ID: 17646845
[TBL] [Abstract][Full Text] [Related]
32. Multiple red cell alloantibodies, including anti-Dib, after allogeneic ABO-matched peripheral blood progenitor cell transplantation.
Zupańska B; Zaucha JM; Michalewska B; Malinowska A; Brojer E; Hellmann A
Transfusion; 2005 Jan; 45(1):16-20. PubMed ID: 15647013
[TBL] [Abstract][Full Text] [Related]
33. ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning.
Badros A; Tricot G; Toor A; Morris C; Guo C; Munshi N; Barlogie B; Cottler-Fox M
Transfusion; 2002 Feb; 42(2):205-9. PubMed ID: 11896336
[TBL] [Abstract][Full Text] [Related]
34. Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia.
Benjamin RJ; Connors JM; McGurk S; Churchill WH; Antin JH
Biol Blood Marrow Transplant; 1998; 4(3):151-6. PubMed ID: 9923413
[TBL] [Abstract][Full Text] [Related]
35. Pre-transplant reduction of isohaemagglutinin titres by donor group plasma infusion does not reduce the incidence of pure red cell aplasia in major ABO-mismatched transplants.
Damodar S; George B; Mammen J; Mathews V; Srivastava A; Chandy M
Bone Marrow Transplant; 2005 Aug; 36(3):233-5. PubMed ID: 15908965
[TBL] [Abstract][Full Text] [Related]
36. Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
Helbig G; Stella-Holowiecka B; Krawczyk-Kulis M; Wojnar J; Markiewicz M; Wojciechowska-Sadus M; Kopera M; Kruzel T; Najda J; Nowak K; Holowiecki J
Haematologica; 2005 Nov; 90 Suppl():ECR33. PubMed ID: 16266924
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic peripheral blood hematopoietic stem cell transplantation: guidelines for red blood cell immuno-hematological assessment and transfusion practice.Société Française de Greffe de Moelle.
Lapierre V; Kuentz M; Tiberghien P
Bone Marrow Transplant; 2000 Mar; 25(5):507-12. PubMed ID: 10713627
[TBL] [Abstract][Full Text] [Related]
38. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
Rowley SD; Liang PS; Ulz L
Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
[TBL] [Abstract][Full Text] [Related]
39. Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation.
Franchini M; Gandini G; Aprili G
Bone Marrow Transplant; 2004 Jun; 33(12):1169-72. PubMed ID: 15094753
[TBL] [Abstract][Full Text] [Related]
40. Transfusion policy in ABO-incompatible allogeneic stem cell transplantation.
Worel N; Panzer S; Reesink HW; Linkesch W; Dickmeiss E; Fischer-Nielsen A; Hölig K; Stachel D; Zimmermann R; Holter W; Coluccia P; Brilhante D; Watz E; Sigle JP; Gratwohl A; Buser A; Arslan O; Regan F; Edwards M
Vox Sang; 2010 Apr; 98(3 Pt 2):455-67. PubMed ID: 20070647
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]